Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...

David Roche of Quantum Strategy discusses his optimism for the new German government following their recent elections. He believes the new government will be able enact reforms both domestically and ...

The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.

Both Viking and Roche are attempting to horn in on this market, however. Yesterday, Viking signed a "broad manufacturing agreement" with Germany's CordenPharma to produce for it a "multi-ton ...

Boardrooms are under increasing pressure - from lawyers as well as staff - to work out how to tread the DEI tightrope.